Global Microbiomes Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Publisher Name :
Date: 21-Sep-2020
No. of pages: 77
Inquire Before Buying

The global microbiomes market is forecasted to reach US$9,376 million in 2024, growing at a CAGR of 135.47% for the period spanning 2018-2024. The factors such as growing geriatric population, rising personal healthcare expenditures, increasing chronic diseases incidence, accelerating personal disposable income and improving consumer confidence index are expected to drive the market. However, growth of the industry would be challenged by intellectual property issues, stringent regulatory framework and manufacturing and technology considerations. Few notable trends include progressing product pipeline, increasing product licensing contracts and inclining microbiome research and development activities. In 2020, the outbreak of COVID-19 pandemic has created a favorable impact on the market as the microbiomes-based products sales increased.

The global microbiomes market can be split on the basis of applications into drugs and diagnostics. Currently, drugs occupies the higher share owing to growth in acceptance of probiotics among population and rising prevalence of autoimmune diseases, cancer and gastrointestinal diseases.

The fastest growing regional market is North America owing to rising incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome along with next-generation sequencing.

Scope of the report:


  • The report provides a comprehensive analysis of the global microbiomes market, segmented into drugs and diagnostics.

  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed.

  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Seres Therapeutics, Inc., Synthetic Biologics, Inc., Evelo Biosciences, Inc., 4D Pharma Plc, Infant Bacterial Therapeutics AB and Takeda Pharmaceutical Company Limited) are also presented in detail.


Key Target Audience:


  • Microbiome-based Manufacturers

  • End Users

  • Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

Global Microbiomes Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Table of Contents

1. Market Overview
1.1 Introduction
1.2 Associated Microbiomes Disorders
1.3 Upcoming Microbiomes-based Products

2. Impact of COVID-19
2.1 Introduction
2.2 Decline in Global GDP Growth
2.3 Change in Organic Traffic 
2.4 Growth in Spending on Healthcare

3. Global Microbiomes Market Analysis
3.1 Global Microbiomes Market Value
3.2 Global Microbiomes Market Value by Applications
3.2.1 Global Microbiomes Drugs Market Value 
3.2.2 Global Microbiomes Drugs Market Value by Therapeutic Area
3.2.3 Global Gastroenterology Microbiomes Drugs Market Value 
3.2.4 Global Infectious Disease Microbiomes Drugs Market Value 
3.2.5 Global Metabolic Disease Microbiomes Drugs Market Value 
3.2.6 Global Oncology Microbiomes Drugs Market Value 
3.2.7 Global Immunology Microbiomes Drugs Market Value 
3.2.8 Global Microbiomes Drugs Market Value by Technology 
3.2.9 Global Microbiomes Diagnostics Market Value 
3.3 Global Microbiomes Market Value by Products
3.3.1 Global Probiotics Microbiomes Market Value
3.3.2 Global Prebiotics Microbiomes Market Value 
3.4 Global Microbiomes Market Value by Region

4. Regional Microbiomes Market Analysis
4.1 North America Microbiomes Market Value 
4.2 Europe Microbiomes Market Value 
4.3 Asia-Pacific Microbiomes Market Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Growing Geriatric Population
5.1.2 Rising Personal HealthCare Expenditures 
5.1.3 Increasing Chronic Diseases Incidence
5.1.4 Accelerating Personal Disposable Income
5.1.5 Improving Consumer Confidence Index 
5.2 Key Trends and Developments
5.2.1 Progressing Product Pipeline
5.2.2 Increasing Product Licensing Contracts
5.2.3 Inclining Microbiome Research and Development Activities 
5.3 Challenges
5.3.1 Intellectual Property Issues
5.3.2 Stringent Regulatory Framework
5.3.3 Manufacturing and Technology Considerations

6. Competitive Landscape
6.1 Global Microbiomes Market
6.1.1 Key Players – Market Cap Comparison 
6.1.2 Key Players – Research and Development Expenditures Comparison 
6.1.3 Key Players – Product Comparison

7. Company Profiles
7.1 Seres Therapeutics, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Synthetic Biologics, Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Evelo Biosciences, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 4D Pharma Plc
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Infant Bacterial Therapeutics AB
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Takeda Pharmaceutical Company Limited
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies

List of Tables

Association of the Gut Microbiome with Therapeutic Effects of Drugs
Global Microbiome-based Product Pipelines
Global Microbiome Licensing Deals (2015-2018)
Key Players – Market Cap Comparison (2020)
Key Players – Product Comparison (2020)
Evelo Biosciences Product Pipeline
4D Pharma Product Pipeline

List of Figures

Global GDP Growth Rate (2005-2020)
Organic Traffic Growth or Decline due to COVID-19 (2020)
The U.S. Government Share of Healthcare Spending (2020-2027)
Global Microbiomes Market Value (2018-2024)
Global Microbiomes Market Value by Applications (2019)
Global Microbiomes Drugs Market Value (2018-2024)
Global Microbiomes Drugs Market Value by Therapeutic Area (2019)
Global Gastroenterology Microbiomes Drugs Market Value (2018-2024)
Global Infectious Disease Microbiomes Drugs Market Value (2018-2024)
Global Metabolic Disease Microbiomes Drugs Market Value (2018-2024)
Global Oncology Microbiomes Drugs Market Value (2018-2024)
Global Immunology Microbiomes Drugs Market Value (2018-2024)
Global Microbiomes Drugs Market Value by Technology (2019)
Global Microbiomes Diagnostics Market Value (2018-2024)
Global Microbiomes Market Value by Products (2019)
Global Probiotics Microbiomes Market Value (2018-2024)
Global Prebiotics Microbiomes Market Value (2018-2024)
Global Microbiomes Market Value by Region (2019)
North America Microbiomes Market Value (2018-2024)
Europe Microbiomes Market Value (2018-2024)
Asia-Pacific Microbiomes Market Value (2018-2024)
Global Geriatric Population (2015-2019)
Global Healthcare Expenditure per Capita (2015-2019)
Global Chronic Diseases Growth (2019)
Global Gross National Income (GNI) per Capita (2015-2019)
Consumer Confidence Index in US and Europe (2015-2019)
Global Microbiome Research and Development Activities (2015-2019)
Key Players – Research and Development Expenditures Comparison (2018/2019)
Seres Therapeutics Revenues and Net Loss (2015-2019)
Synthetic Biologics Net Loss (2015-2019)
Evelo Biosciences Net Loss (2016-2019)
4D Pharma Revenues and Net Loss (2015-2019)
IBT Net Loss (2015-2019)
Takeda Revenues and Net Profit (2016-2020)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs